These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15974987)

  • 1. Conformational properties of HIV-1 gp120/V3 immunogenic domains.
    Galanakis PA; Spyroulias GA; Rizos A; Samolis P; Krambovitis E
    Curr Med Chem; 2005; 12(13):1551-68. PubMed ID: 15974987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.
    Nehete PN; Vela EM; Hossain MM; Sarkar AK; Yahi N; Fantini J; Sastry KJ
    Antiviral Res; 2002 Dec; 56(3):233-51. PubMed ID: 12406507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
    Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
    Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.
    Derdeyn CA; Decker JM; Sfakianos JN; Zhang Z; O'Brien WA; Ratner L; Shaw GM; Hunter E
    J Virol; 2001 Sep; 75(18):8605-14. PubMed ID: 11507206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
    Foda M; Harada S; Maeda Y
    Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120.
    Chandramouli B; Chillemi G; Giombini E; Capobianchi MR; Rozera G; Desideri A
    J Biomol Struct Dyn; 2013 Apr; 31(4):403-13. PubMed ID: 22876913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity.
    Xiao X; Phogat S; Shu Y; Phogat A; Chow YH; Wei OL; Goldstein H; Broder CC; Dimitrov DS
    Vaccine; 2003 Oct; 21(27-30):4275-84. PubMed ID: 14505910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of V3 loop flexibility and net charge in the context of co-receptor recognition. A molecular dynamics study on HIV gp120.
    Chandramouli B; Chillemi G; Abbate I; Capobianchi MR; Rozera G; Desideri A
    J Biomol Struct Dyn; 2012; 29(5):879-91. PubMed ID: 22292949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV. Envelope's letters boxed into shape.
    Moore JP; Binley J
    Nature; 1998 Jun; 393(6686):630-1. PubMed ID: 9641673
    [No Abstract]   [Full Text] [Related]  

  • 12. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
    PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.
    Xiang SH; Finzi A; Pacheco B; Alexander K; Yuan W; Rizzuto C; Huang CC; Kwong PD; Sodroski J
    J Virol; 2010 Apr; 84(7):3147-61. PubMed ID: 20089638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
    McCaffrey RA; Saunders C; Hensel M; Stamatatos L
    J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
    Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 infection and chemokine receptor modulation.
    Ruibal-Ares BH; Belmonte L; Baré PC; Parodi CM; Massud I; de Bracco MM
    Curr HIV Res; 2004 Jan; 2(1):39-50. PubMed ID: 15053339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F; Borman AM; Brand D; Girard M
    AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
    Liu S; Fan S; Sun Z
    J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.